111 Inc represents several core values and a strong corporate philosophy. The company prioritizes innovation and technological advancements, aiming to transform the healthcare industry through its integrated online and offline platforms. 111 Inc focuses on providing convenient access to pharmaceuticals and medical services, leveraging advanced technologies like big data analytics and AI-driven solutions. By optimizing pharmaceutical supply chains and enhancing pharmaceutical product selection, they strive to improve healthcare outcomes and ensure customer satisfaction. With a commitment to quality, efficiency, and customer-centricity, 111 Inc aims to revolutionize the healthcare experience and become a leader in the industry.

111 Inc is primarily present in mainland China.

111 Inc has achieved significant milestones since its inception. These include expanding its online platform and offline pharmacy network, enhancing customer experience through technology integration, and partnering with various leading pharmaceutical brands. The company continuously strives to revolutionize the supply chain in the healthcare industry by utilizing cutting-edge technologies and providing efficient solutions. Additionally, 111 Inc has successfully introduced intelligent healthcare services, such as AI-based prescription screening and remote consultation services, further establishing its position as a trusted healthcare platform.

111 Inc is a leading integrated pharmacy and healthcare platform company in China. Founded in 2010, the company has rapidly expanded its business operations and established itself as a trusted provider of pharmaceutical products and healthcare services. With a focus on serving the needs of both online and offline pharmacies, 111 Inc has developed advanced technologies and comprehensive supply chain capabilities. Through partnerships with various medical and healthcare institutions, the company is committed to improving efficiency and accessibility in the healthcare industry. With its strong market presence and dedication to innovation, 111 Inc continues to play a vital role in shaping the future of healthcare in China.

The main competitors of 111 Inc in the market include JD Health, Alibaba Health, and HC International.

111 Inc is primarily active in the healthcare industry.

The business model of 111 Inc, a leading integrated online and offline healthcare platform in China, revolves around providing pharmaceutical and healthcare product distribution and retail services. The company combines its comprehensive online platform with a vast offline network of partner pharmacies and medical centers to offer an array of pharmaceutical products and value-added services. Through efficient supply chain management, electronic prescription solutions, and personalized healthcare services, 111 Inc aims to enhance efficiency and affordability in the healthcare industry. By integrating technology, logistics, and healthcare expertise, 111 Inc seeks to streamline the delivery of quality medical supplies and services, ultimately benefiting both consumers and healthcare providers.

111 KGV ir 20,12.

111 KUV ir 0,33.

AlleAktien kvalitātes vērtējums 111 ir 4/10.

gaidāmā 111 apgrozījums ir 28,31 miljardi CNY.

gaidāmā 111 peļņa ir 465,26 milj. CNY.

111 Inc is a Chinese company that was founded in 2015 and is headquartered in Shanghai. It offers a wide range of products and services in the healthcare sector. The company aims to revolutionize the healthcare industry through technology and facilitate access to healthcare services. The core business of 111 Inc is the sale of medications and other healthcare products. It operates an e-commerce platform that offers a wide range of products, including prescription drugs, over-the-counter medications, vitamins, dietary supplements, and medical devices. Customers can order products online and have them delivered within 24 hours. 111 Inc also provides healthcare applications and services to facilitate access to high-quality healthcare for customers. The company has developed a number of mobile apps that make healthcare at home easier. One of the most well-known applications is the "111 Online Doctor," which gives customers access to medical consultations and diagnoses without having to leave their homes. Customers can enter their symptoms into the app, and a qualified doctor will respond and make a diagnosis. In this case, most services are free. In addition, the company also operates a network of its own pharmacies. These pharmacies offer customers medications, diagnostic tests, and other healthcare services. The pharmacies specialize in storing and packaging medications, minimizing errors and ensuring the quality of the medications. Infrastructure services are another division of 111 Inc. It offers both offline and online services. Offline services include renting storage spaces, managing business premises, and cleaning offices and buildings. Online services involve hosting e-commerce websites, managing customer data, and other IT-related tasks. To make their services more effective, 111 Inc relies on big data and artificial intelligence technology. The company collects data from customers, doctors, and other healthcare providers and uses it to analyze trends and patterns in the healthcare market. This allows the company to respond to changes and issues in real time. 111 Inc's business model is based on innovation in the healthcare sector and the simplified provision of healthcare products and services. The company relies on new technologies to reach and serve customers better. With its wide range of products, mobile apps, network of pharmacies, and the support of big data and artificial intelligence, the company is on a growth path and gaining more and more customers in the Chinese market.

111 izmaksā dividendes 0 CNY, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt 111 vai uzņēmums nedod dividendes.

111 ISIN ir US68247Q1022.

111 WKN ir A2N465.

111 simbols ir YI.

Pēdējo 12 mēnešu laikā 111 maksāja dividendes apmērā. Tas atbilst aptuveni dividendes ražībai. Nākamajos 12 mēnešos 111 plāno maksāt dividendes 0 CNY apmērā.

111 pašreizējā dividendu rentabilitāte ir .

111 maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos .

111 pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 CNY. Tas atbilst dividendes ražībai 0 %.

111 tiek piešķirts nozarei "Necikliskais patēriņš".

Lai saņemtu pēdējo dividendu 111 apmērā 0 CNY, kas tika izmaksāta 15.02.2025., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 15.02.2025..

Pēdējās dividendes izmaksa notika 15.02.2025..

Gadā 2024, 111 izmaksāja 0 CNY dividendes.

111 dividendes tiek izmaksātas CNY.